|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
Z104295-1-O |
Cyclin-dependent Kinase 4/cyclin D1 (cluster #1 Of 2), Other |
Other |
180 |
0.33 |
Binding ≤ 10μM
|
Z80928-5-O |
HCT-116 (Colon Carcinoma Cells) (cluster #5 Of 9), Other |
Other |
470 |
0.31 |
Functional ≤ 10μM
|
Z81024-1-O |
NCI-H460 (Non-small Cell Lung Carcinoma) (cluster #1 Of 8), Other |
Other |
610 |
0.30 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
3.81 |
4.26 |
-10.59 |
3 |
7 |
0 |
100 |
385.379 |
2 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
4.21 |
9.9 |
-24.79 |
3 |
5 |
1 |
64 |
297.382 |
7 |
↓
|
Hi
High (pH 8-9.5)
|
4.21 |
9.53 |
-8.73 |
2 |
5 |
0 |
63 |
296.374 |
7 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
AMPC-1-B |
Beta-lactamase (cluster #1 Of 6), Bacterial |
Bacteria |
8000 |
0.30 |
Binding ≤ 10μM
|
AMPH-1-B |
Penicillin-binding Protein AmpH (cluster #1 Of 2), Bacterial |
Bacteria |
8000 |
0.30 |
Binding ≤ 10μM
|
MDH-1-B |
Malate Dehydrogenase (cluster #1 Of 1), Bacterial |
Bacteria |
8000 |
0.30 |
Binding ≤ 10μM
|
CTRB1-3-E |
Beta-chymotrypsin (cluster #3 Of 3), Eukaryotic |
Eukaryotes |
10000 |
0.29 |
Binding ≤ 10μM
|
GLI1-1-E |
Zinc Finger Protein GLI1 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
1800 |
0.34 |
Binding ≤ 10μM
|
GLI2-1-E |
Zinc Finger Protein GLI2 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
2700 |
0.32 |
Binding ≤ 10μM
|
JAK3-2-E |
Tyrosine-protein Kinase JAK3 (cluster #2 Of 2), Eukaryotic |
Eukaryotes |
61 |
0.42 |
Binding ≤ 10μM
|
KCC2A-1-E |
CaM Kinase II Alpha (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
184 |
0.39 |
Binding ≤ 10μM
|
KCC2B-1-E |
CaM Kinase II Beta (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
184 |
0.39 |
Binding ≤ 10μM
|
KCC2D-1-E |
CaM Kinase II Delta (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
184 |
0.39 |
Binding ≤ 10μM
|
KCC2G-1-E |
CaM Kinase II Gamma (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
184 |
0.39 |
Binding ≤ 10μM
|
KGP1-1-E |
CGMP-dependent Protein Kinase 1 Beta (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
650 |
0.36 |
Binding ≤ 10μM |
KPCA-1-E |
Protein Kinase C Alpha (cluster #1 Of 6), Eukaryotic |
Eukaryotes |
2450 |
0.33 |
Binding ≤ 10μM |
KPCB-1-E |
Protein Kinase C Beta (cluster #1 Of 4), Eukaryotic |
Eukaryotes |
680 |
0.36 |
Binding ≤ 10μM |
KPCD-1-E |
Protein Kinase C Delta (cluster #1 Of 4), Eukaryotic |
Eukaryotes |
2450 |
0.33 |
Binding ≤ 10μM |
KPCD1-2-E |
Protein Kinase C Mu (cluster #2 Of 3), Eukaryotic |
Eukaryotes |
2450 |
0.33 |
Binding ≤ 10μM |
KPCD3-2-E |
Protein Kinase C Nu (cluster #2 Of 3), Eukaryotic |
Eukaryotes |
2450 |
0.33 |
Binding ≤ 10μM |
KPCE-1-E |
Protein Kinase C Epsilon (cluster #1 Of 5), Eukaryotic |
Eukaryotes |
2450 |
0.33 |
Binding ≤ 10μM |
KPCG-1-E |
Protein Kinase C Gamma (cluster #1 Of 4), Eukaryotic |
Eukaryotes |
680 |
0.36 |
Binding ≤ 10μM |
KPCI-2-E |
Protein Kinase C Iota (cluster #2 Of 3), Eukaryotic |
Eukaryotes |
2450 |
0.33 |
Binding ≤ 10μM |
KPCL-2-E |
Protein Kinase C Eta (cluster #2 Of 4), Eukaryotic |
Eukaryotes |
680 |
0.36 |
Binding ≤ 10μM |
KPCT-1-E |
Protein Kinase C Theta (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
680 |
0.36 |
Binding ≤ 10μM |
KPCZ-1-E |
Protein Kinase C Zeta (cluster #1 Of 5), Eukaryotic |
Eukaryotes |
2450 |
0.33 |
Binding ≤ 10μM |
M3K11-1-E |
Mitogen-activated Protein Kinase Kinase Kinase 11 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
49 |
0.43 |
Binding ≤ 10μM
|
M3K9-1-E |
Mitogen-activated Protein Kinase Kinase Kinase 9 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
138 |
0.40 |
Binding ≤ 10μM
|
MYLK-1-E |
Myosin Light Chain Kinase, Smooth Muscle (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
2800 |
0.32 |
Binding ≤ 10μM |
Z104295-1-O |
Cyclin-dependent Kinase 4/cyclin D1 (cluster #1 Of 2), Other |
Other |
830 |
0.35 |
Binding ≤ 10μM
|
Z80035-1-O |
B16 (Melanoma Cells) (cluster #1 Of 7), Other |
Other |
4800 |
0.31 |
Functional ≤ 10μM
|
Z80362-1-O |
P388 (Lymphoma Cells) (cluster #1 Of 8), Other |
Other |
4000 |
0.31 |
Functional ≤ 10μM
|
Z80928-5-O |
HCT-116 (Colon Carcinoma Cells) (cluster #5 Of 9), Other |
Other |
1720 |
0.34 |
Functional ≤ 10μM
|
Z81024-8-O |
NCI-H460 (Non-small Cell Lung Carcinoma) (cluster #8 Of 8), Other |
Other |
3200 |
0.32 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
3.63 |
6.35 |
-15.15 |
3 |
4 |
0 |
61 |
311.344 |
0 |
↓
|
|
|
Analogs
-
4689165
-
Draw
Identity
99%
90%
80%
70%
Vendors
And 10 More
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
Z80928-5-O |
HCT-116 (Colon Carcinoma Cells) (cluster #5 Of 9), Other |
Other |
6 |
0.32 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
8.53 |
16.91 |
-70.86 |
4 |
4 |
2 |
60 |
464.572 |
2 |
↓
|
Ref
Reference (pH 7)
|
8.53 |
16.84 |
-71.05 |
4 |
4 |
2 |
60 |
464.572 |
2 |
↓
|
|
|
|
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
And 1 More
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
CCNB1-2-E |
G2/mitotic-specific Cyclin B1 (cluster #2 Of 2), Eukaryotic |
Eukaryotes |
1130 |
0.33 |
Binding ≤ 10μM
|
CCNB2-2-E |
G2/mitotic-specific Cyclin B2 (cluster #2 Of 2), Eukaryotic |
Eukaryotes |
1130 |
0.33 |
Binding ≤ 10μM
|
CCNB3-2-E |
G2/mitotic-specific Cyclin B3 (cluster #2 Of 2), Eukaryotic |
Eukaryotes |
1130 |
0.33 |
Binding ≤ 10μM
|
CCNE1-2-E |
G1/S-specific Cyclin E1 (cluster #2 Of 2), Eukaryotic |
Eukaryotes |
900 |
0.34 |
Binding ≤ 10μM
|
CCNE2-2-E |
G1/S-specific Cyclin E2 (cluster #2 Of 2), Eukaryotic |
Eukaryotes |
900 |
0.34 |
Binding ≤ 10μM
|
CDK1-3-E |
Cyclin-dependent Kinase 1 (cluster #3 Of 4), Eukaryotic |
Eukaryotes |
1130 |
0.33 |
Binding ≤ 10μM
|
CDK2-2-E |
Cyclin-dependent Kinase 2 (cluster #2 Of 5), Eukaryotic |
Eukaryotes |
900 |
0.34 |
Binding ≤ 10μM
|
KCC2A-1-E |
CaM Kinase II Alpha (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
25 |
0.43 |
Binding ≤ 10μM
|
KCC2B-1-E |
CaM Kinase II Beta (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
25 |
0.43 |
Binding ≤ 10μM
|
KCC2D-1-E |
CaM Kinase II Delta (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
25 |
0.43 |
Binding ≤ 10μM
|
KCC2G-1-E |
CaM Kinase II Gamma (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
25 |
0.43 |
Binding ≤ 10μM
|
KPCA-1-E |
Protein Kinase C Alpha (cluster #1 Of 6), Eukaryotic |
Eukaryotes |
550 |
0.35 |
Binding ≤ 10μM |
KPCB-1-E |
Protein Kinase C Beta (cluster #1 Of 4), Eukaryotic |
Eukaryotes |
550 |
0.35 |
Binding ≤ 10μM |
KPCD-1-E |
Protein Kinase C Delta (cluster #1 Of 4), Eukaryotic |
Eukaryotes |
550 |
0.35 |
Binding ≤ 10μM |
KPCD1-2-E |
Protein Kinase C Mu (cluster #2 Of 3), Eukaryotic |
Eukaryotes |
550 |
0.35 |
Binding ≤ 10μM |
KPCD3-2-E |
Protein Kinase C Nu (cluster #2 Of 3), Eukaryotic |
Eukaryotes |
550 |
0.35 |
Binding ≤ 10μM |
KPCE-1-E |
Protein Kinase C Epsilon (cluster #1 Of 5), Eukaryotic |
Eukaryotes |
550 |
0.35 |
Binding ≤ 10μM |
KPCG-1-E |
Protein Kinase C Gamma (cluster #1 Of 4), Eukaryotic |
Eukaryotes |
550 |
0.35 |
Binding ≤ 10μM |
KPCI-2-E |
Protein Kinase C Iota (cluster #2 Of 3), Eukaryotic |
Eukaryotes |
550 |
0.35 |
Binding ≤ 10μM |
KPCL-2-E |
Protein Kinase C Eta (cluster #2 Of 4), Eukaryotic |
Eukaryotes |
550 |
0.35 |
Binding ≤ 10μM |
KPCT-1-E |
Protein Kinase C Theta (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
550 |
0.35 |
Binding ≤ 10μM |
KPCZ-1-E |
Protein Kinase C Zeta (cluster #1 Of 5), Eukaryotic |
Eukaryotes |
550 |
0.35 |
Binding ≤ 10μM |
Z104295-1-O |
Cyclin-dependent Kinase 4/cyclin D1 (cluster #1 Of 2), Other |
Other |
163 |
0.38 |
Binding ≤ 10μM
|
Z50530-1-O |
Human Herpesvirus 5 (cluster #1 Of 5), Other |
Other |
200 |
0.38 |
Functional ≤ 10μM
|
Z80362-1-O |
P388 (Lymphoma Cells) (cluster #1 Of 8), Other |
Other |
4000 |
0.30 |
Functional ≤ 10μM
|
Z80928-5-O |
HCT-116 (Colon Carcinoma Cells) (cluster #5 Of 9), Other |
Other |
850 |
0.34 |
Functional ≤ 10μM
|
Z81024-8-O |
NCI-H460 (Non-small Cell Lung Carcinoma) (cluster #8 Of 8), Other |
Other |
590 |
0.35 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
3.75 |
5.67 |
-11.48 |
3 |
5 |
0 |
82 |
325.327 |
0 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
HDA10-1-E |
Histone Deacetylase 10 (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
8 |
0.40 |
Binding ≤ 10μM |
HDA11-1-E |
Histone Deacetylase 11 (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
6 |
0.41 |
Binding ≤ 10μM |
HDAC1-2-E |
Histone Deacetylase 1 (cluster #2 Of 4), Eukaryotic |
Eukaryotes |
9 |
0.40 |
Binding ≤ 10μM
|
HDAC2-1-E |
Histone Deacetylase 2 (cluster #1 Of 4), Eukaryotic |
Eukaryotes |
7 |
0.41 |
Binding ≤ 10μM
|
HDAC3-1-E |
Histone Deacetylase 3 (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
9 |
0.40 |
Binding ≤ 10μM
|
HDAC4-1-E |
Histone Deacetylase 4 (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
500 |
0.32 |
Binding ≤ 10μM
|
HDAC5-1-E |
Histone Deacetylase 5 (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
6 |
0.41 |
Binding ≤ 10μM |
HDAC6-1-E |
Histone Deacetylase 6 (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
10 |
0.40 |
Binding ≤ 10μM
|
HDAC7-1-E |
Histone Deacetylase 7 (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
9500 |
0.25 |
Binding ≤ 10μM
|
HDAC8-1-E |
Histone Deacetylase 8 (cluster #1 Of 4), Eukaryotic |
Eukaryotes |
400 |
0.32 |
Binding ≤ 10μM
|
HDAC9-1-E |
Histone Deacetylase 9 (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
9000 |
0.25 |
Binding ≤ 10μM
|
Z80877-2-O |
NCI-H1299 (Non-small Cell Lung Carcinoma) (cluster #2 Of 2), Other |
Other |
150 |
0.34 |
Functional ≤ 10μM
|
Z80928-5-O |
HCT-116 (Colon Carcinoma Cells) (cluster #5 Of 9), Other |
Other |
50 |
0.37 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
2.58 |
-3.07 |
-53.1 |
5 |
6 |
1 |
89 |
380.468 |
9 |
↓
|
Hi
High (pH 8-9.5)
|
2.58 |
-2.5 |
-87.1 |
4 |
6 |
0 |
92 |
379.46 |
9 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
And 8 More
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
KCNH2-2-E |
HERG (cluster #2 Of 5), Eukaryotic |
Eukaryotes |
210 |
0.33 |
Binding ≤ 10μM
|
S22A1-1-E |
Solute Carrier Family 22 Member 1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
5000 |
0.27 |
Binding ≤ 10μM
|
TOP2A-1-E |
DNA Topoisomerase II Alpha (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
9940 |
0.25 |
Binding ≤ 10μM
|
TOP2B-1-E |
DNA Topoisomerase II Beta (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
720 |
0.31 |
Binding ≤ 10μM |
TOP1-1-E |
DNA Topoisomerase I (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
20 |
0.38 |
Functional ≤ 10μM
|
TOP2A-1-E |
DNA Topoisomerase II Alpha (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
20 |
0.38 |
Functional ≤ 10μM
|
TOP2B-1-E |
DNA Topoisomerase II Beta (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
20 |
0.38 |
Functional ≤ 10μM
|
ADO-1-E |
Aldehyde Oxidase (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
6400 |
0.26 |
ADME/T ≤ 10μM
|
CP2D6-2-E |
Cytochrome P450 2D6 (cluster #2 Of 3), Eukaryotic |
Eukaryotes |
7500 |
0.26 |
ADME/T ≤ 10μM
|
Z103205-3-O |
A431 (cluster #3 Of 4), Other |
Other |
5890 |
0.26 |
Functional ≤ 10μM
|
Z50425-3-O |
Plasmodium Falciparum (cluster #3 Of 22), Other |
Other |
600 |
0.31 |
Functional ≤ 10μM
|
Z50460-4-O |
Leishmania Major (cluster #4 Of 4), Other |
Other |
1500 |
0.29 |
Functional ≤ 10μM
|
Z80064-8-O |
CCRF-CEM (T-cell Leukemia) (cluster #8 Of 9), Other |
Other |
139 |
0.34 |
Functional ≤ 10μM
|
Z80084-1-O |
CEM-VLB (Vinblastine-resistant T-cell Leukemia Cells) (cluster #1 Of 2), Other |
Other |
520 |
0.31 |
Functional ≤ 10μM
|
Z80085-1-O |
CEM-VM1 (Etoposide-resistant T-cell Leukemia Cells) (cluster #1 Of 2), Other |
Other |
1910 |
0.29 |
Functional ≤ 10μM
|
Z80089-1-O |
CHO-AA8 (cluster #1 Of 2), Other |
Other |
1 |
0.45 |
Functional ≤ 10μM
|
Z80115-1-O |
DC3F (cluster #1 Of 1), Other |
Other |
4 |
0.42 |
Functional ≤ 10μM
|
Z80117-2-O |
DC3F/AD-II (cluster #2 Of 2), Other |
Other |
47 |
0.37 |
Functional ≤ 10μM
|
Z80152-1-O |
HCT-8 (Ileocecal Adenocarcinoma) (cluster #1 Of 2), Other |
Other |
120 |
0.35 |
Functional ≤ 10μM
|
Z80156-1-O |
HL-60 (Promyeloblast Leukemia Cells) (cluster #1 Of 12), Other |
Other |
6 |
0.41 |
Functional ≤ 10μM
|
Z80166-1-O |
HT-29 (Colon Adenocarcinoma Cells) (cluster #1 Of 12), Other |
Other |
559 |
0.31 |
Functional ≤ 10μM |
Z80186-6-O |
K562 (Erythroleukemia Cells) (cluster #6 Of 11), Other |
Other |
23 |
0.38 |
Functional ≤ 10μM
|
Z80193-2-O |
L1210 (Lymphocytic Leukemia Cells) (cluster #2 Of 12), Other |
Other |
50 |
0.37 |
Functional ≤ 10μM
|
Z80224-5-O |
MCF7 (Breast Carcinoma Cells) (cluster #5 Of 14), Other |
Other |
75 |
0.36 |
Functional ≤ 10μM
|
Z80227-2-O |
MCF7-ADR (Breast Carcinoma Cells) (cluster #2 Of 2), Other |
Other |
1165 |
0.30 |
Functional ≤ 10μM
|
Z80244-7-O |
MDA-MB-468 (Breast Adenocarcinoma) (cluster #7 Of 7), Other |
Other |
490 |
0.32 |
Functional ≤ 10μM
|
Z80322-1-O |
NCI-H358 (Lung Carcinama Cells) (cluster #1 Of 2), Other |
Other |
150 |
0.34 |
Functional ≤ 10μM
|
Z80362-1-O |
P388 (Lymphoma Cells) (cluster #1 Of 8), Other |
Other |
890 |
0.30 |
Functional ≤ 10μM
|
Z80475-3-O |
SK-BR-3 (Breast Adenocarcinoma) (cluster #3 Of 3), Other |
Other |
60 |
0.36 |
Functional ≤ 10μM
|
Z80601-1-O |
XRS6 (cluster #1 Of 1), Other |
Other |
240 |
0.33 |
Functional ≤ 10μM
|
Z80608-4-O |
ZR-75-1 (Breast Carcinoma Cells) (cluster #4 Of 4), Other |
Other |
180 |
0.34 |
Functional ≤ 10μM
|
Z80612-1-O |
2008 (Ovarian Carcinoma Cells) (cluster #1 Of 2), Other |
Other |
4310 |
0.27 |
Functional ≤ 10μM
|
Z80682-1-O |
A549 (Lung Carcinoma Cells) (cluster #1 Of 11), Other |
Other |
3520 |
0.27 |
Functional ≤ 10μM
|
Z80712-7-O |
T47D (Breast Carcinoma Cells) (cluster #7 Of 7), Other |
Other |
220 |
0.33 |
Functional ≤ 10μM
|
Z80819-1-O |
J774.2 (cluster #1 Of 1), Other |
Other |
1485 |
0.29 |
Functional ≤ 10μM |
Z80846-2-O |
F460pv8/eto Cell Line (cluster #2 Of 2), Other |
Other |
40 |
0.37 |
Functional ≤ 10μM
|
Z80889-2-O |
NCI-H322M (Non-small Cell Lung Carcinoma Cells) (cluster #2 Of 3), Other |
Other |
210 |
0.33 |
Functional ≤ 10μM
|
Z80928-5-O |
HCT-116 (Colon Carcinoma Cells) (cluster #5 Of 9), Other |
Other |
700 |
0.31 |
Functional ≤ 10μM
|
Z81024-8-O |
NCI-H460 (Non-small Cell Lung Carcinoma) (cluster #8 Of 8), Other |
Other |
60 |
0.36 |
Functional ≤ 10μM
|
Z81034-6-O |
A2780 (Ovarian Carcinoma Cells) (cluster #6 Of 10), Other |
Other |
100 |
0.35 |
Functional ≤ 10μM
|
Z81072-6-O |
Jurkat (Acute Leukemic T-cells) (cluster #6 Of 10), Other |
Other |
80 |
0.35 |
Functional ≤ 10μM
|
Z81160-1-O |
Lewis Lung Carcinoma Cell Line (cluster #1 Of 1), Other |
Other |
12 |
0.40 |
Functional ≤ 10μM
|
Z81164-1-O |
LL Cell Line (cluster #1 Of 2), Other |
Other |
12 |
0.40 |
Functional ≤ 10μM
|
Z81167-1-O |
LLTC Cell Line (cluster #1 Of 1), Other |
Other |
12 |
0.40 |
Functional ≤ 10μM
|
Z81244-1-O |
J774 (Macrophage Cells) (cluster #1 Of 1), Other |
Other |
901 |
0.30 |
Functional ≤ 10μM |
Z81247-2-O |
HeLa (Cervical Adenocarcinoma Cells) (cluster #2 Of 9), Other |
Other |
9500 |
0.25 |
Functional ≤ 10μM
|
Z81252-10-O |
MDA-MB-231 (Breast Adenocarcinoma Cells) (cluster #10 Of 11), Other |
Other |
140 |
0.34 |
Functional ≤ 10μM
|
Z81280-1-O |
NCI-H226 (Non-small Cell Lung Carcinoma Cells) (cluster #1 Of 3), Other |
Other |
1010 |
0.30 |
Functional ≤ 10μM
|
Z81284-2-O |
NCI-H647 (cluster #2 Of 2), Other |
Other |
70 |
0.36 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
4.91 |
6.33 |
-44.52 |
2 |
6 |
0 |
84 |
393.468 |
5 |
↓
|
Hi
High (pH 8-9.5)
|
4.91 |
5.83 |
-16.62 |
2 |
6 |
0 |
80 |
393.468 |
5 |
↓
|
Hi
High (pH 8-9.5)
|
4.91 |
5.94 |
-47.33 |
1 |
6 |
-1 |
82 |
392.46 |
5 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
4.52 |
0.23 |
-9.94 |
0 |
4 |
0 |
38 |
299.761 |
3 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
Z80712-7-O |
T47D (Breast Carcinoma Cells) (cluster #7 Of 7), Other |
Other |
78 |
0.43 |
Functional ≤ 10μM
|
Z80928-5-O |
HCT-116 (Colon Carcinoma Cells) (cluster #5 Of 9), Other |
Other |
5500 |
0.32 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
4.43 |
11.66 |
-11.35 |
0 |
3 |
0 |
45 |
296.329 |
2 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
Z80712-7-O |
T47D (Breast Carcinoma Cells) (cluster #7 Of 7), Other |
Other |
210 |
0.49 |
Functional ≤ 10μM
|
Z80928-5-O |
HCT-116 (Colon Carcinoma Cells) (cluster #5 Of 9), Other |
Other |
300 |
0.48 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
4.46 |
0.23 |
-9.32 |
0 |
3 |
0 |
29 |
269.735 |
2 |
↓
|
|
|
Analogs
-
1316759
-
Draw
Identity
99%
90%
80%
70%
Vendors
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
Z80712-7-O |
T47D (Breast Carcinoma Cells) (cluster #7 Of 7), Other |
Other |
86 |
0.49 |
Functional ≤ 10μM
|
Z80928-5-O |
HCT-116 (Colon Carcinoma Cells) (cluster #5 Of 9), Other |
Other |
130 |
0.48 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
3.07 |
6.74 |
-30.18 |
2 |
4 |
1 |
50 |
266.324 |
2 |
↓
|
Hi
High (pH 8-9.5)
|
3.07 |
6.33 |
-10.45 |
1 |
4 |
0 |
49 |
265.316 |
2 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
And 7 More
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
Z80712-7-O |
T47D (Breast Carcinoma Cells) (cluster #7 Of 7), Other |
Other |
2 |
0.58 |
Functional ≤ 10μM
|
Z80928-5-O |
HCT-116 (Colon Carcinoma Cells) (cluster #5 Of 9), Other |
Other |
3 |
0.57 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
3.60 |
8.9 |
-26.67 |
1 |
4 |
1 |
40 |
280.351 |
3 |
↓
|
Mid
Mid (pH 6-8)
|
3.61 |
8.48 |
-10.2 |
0 |
4 |
0 |
38 |
279.343 |
3 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
CCNB1-2-E |
G2/mitotic-specific Cyclin B1 (cluster #2 Of 2), Eukaryotic |
Eukaryotes |
2100 |
0.31 |
Binding ≤ 10μM
|
CCNB2-2-E |
G2/mitotic-specific Cyclin B2 (cluster #2 Of 2), Eukaryotic |
Eukaryotes |
2100 |
0.31 |
Binding ≤ 10μM
|
CCNB3-2-E |
G2/mitotic-specific Cyclin B3 (cluster #2 Of 2), Eukaryotic |
Eukaryotes |
2100 |
0.31 |
Binding ≤ 10μM
|
CCNE1-2-E |
G1/S-specific Cyclin E1 (cluster #2 Of 2), Eukaryotic |
Eukaryotes |
520 |
0.34 |
Binding ≤ 10μM
|
CCNE2-2-E |
G1/S-specific Cyclin E2 (cluster #2 Of 2), Eukaryotic |
Eukaryotes |
520 |
0.34 |
Binding ≤ 10μM
|
CDK1-1-E |
Cyclin-dependent Kinase 1 (cluster #1 Of 4), Eukaryotic |
Eukaryotes |
2100 |
0.31 |
Binding ≤ 10μM
|
CDK2-2-E |
Cyclin-dependent Kinase 2 (cluster #2 Of 5), Eukaryotic |
Eukaryotes |
520 |
0.34 |
Binding ≤ 10μM
|
E2AK2-1-E |
Interferon-induced, Double-stranded RNA-activated Protein Kinase (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
6000 |
0.28 |
Binding ≤ 10μM |
Z104295-1-O |
Cyclin-dependent Kinase 4/cyclin D1 (cluster #1 Of 2), Other |
Other |
76 |
0.38 |
Binding ≤ 10μM
|
Z80928-5-O |
HCT-116 (Colon Carcinoma Cells) (cluster #5 Of 9), Other |
Other |
2230 |
0.30 |
Functional ≤ 10μM
|
Z81024-1-O |
NCI-H460 (Non-small Cell Lung Carcinoma) (cluster #1 Of 8), Other |
Other |
2760 |
0.30 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
4.53 |
-4.63 |
-9.63 |
3 |
5 |
0 |
81 |
404.223 |
0 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
CYNT-1-B |
Carbonic Anhydrase (cluster #1 Of 3), Bacterial |
Bacteria |
717 |
0.36 |
Binding ≤ 10μM
|
P96878-1-B |
PROBABLE TRANSMEMBRANE CARBONIC ANHYDRASE (CARBONATE DEHYDRATASE) (CARBONIC DEHYDRATASE) (cluster #1 Of 2), Bacterial |
Bacteria |
15 |
0.46 |
Binding ≤ 10μM
|
Y1284-1-B |
Uncharacterized Protein Rv1284/MT1322 (cluster #1 Of 2), Bacterial |
Bacteria |
97 |
0.41 |
Binding ≤ 10μM
|
B5SU02-2-E |
Alpha Carbonic Anhydrase (cluster #2 Of 6), Eukaryotic |
Eukaryotes |
163 |
0.40 |
Binding ≤ 10μM
|
C0IX24-1-E |
Carbonic Anhydrase (cluster #1 Of 5), Eukaryotic |
Eukaryotes |
394 |
0.37 |
Binding ≤ 10μM
|
CAH1-5-E |
Carbonic Anhydrase I (cluster #5 Of 12), Eukaryotic |
Eukaryotes |
97 |
0.41 |
Binding ≤ 10μM
|
CAH12-1-E |
Carbonic Anhydrase XII (cluster #1 Of 9), Eukaryotic |
Eukaryotes |
3 |
0.50 |
Binding ≤ 10μM |
CAH14-1-E |
Carbonic Anhydrase XIV (cluster #1 Of 8), Eukaryotic |
Eukaryotes |
104 |
0.41 |
Binding ≤ 10μM |
CAH15-2-E |
Carbonic Anhydrase 15 (cluster #2 Of 6), Eukaryotic |
Eukaryotes |
72 |
0.42 |
Binding ≤ 10μM
|
CAH2-6-E |
Carbonic Anhydrase II (cluster #6 Of 15), Eukaryotic |
Eukaryotes |
7840 |
0.30 |
Binding ≤ 10μM
|
CAH4-1-E |
Carbonic Anhydrase IV (cluster #1 Of 16), Eukaryotic |
Eukaryotes |
65 |
0.42 |
Binding ≤ 10μM
|
CAH5A-1-E |
Carbonic Anhydrase VA (cluster #1 Of 10), Eukaryotic |
Eukaryotes |
79 |
0.41 |
Binding ≤ 10μM
|
CAH5B-1-E |
Carbonic Anhydrase VB (cluster #1 Of 9), Eukaryotic |
Eukaryotes |
23 |
0.45 |
Binding ≤ 10μM
|
CAH6-7-E |
Carbonic Anhydrase VI (cluster #7 Of 8), Eukaryotic |
Eukaryotes |
47 |
0.43 |
Binding ≤ 10μM
|
CAH9-1-E |
Carbonic Anhydrase IX (cluster #1 Of 11), Eukaryotic |
Eukaryotes |
24 |
0.44 |
Binding ≤ 10μM
|
CAH1-2-E |
Carbonic Anhydrase I (cluster #2 Of 3), Eukaryotic |
Eukaryotes |
31 |
0.44 |
Functional ≤ 10μM
|
CAH2-1-E |
Carbonic Anhydrase II (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
15 |
0.46 |
Functional ≤ 10μM
|
CAH4-1-E |
Carbonic Anhydrase IV (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
65 |
0.42 |
Functional ≤ 10μM
|
CAN-1-F |
Carbonic Anhydrase (cluster #1 Of 3), Fungal |
Fungi |
133 |
0.40 |
Binding ≤ 10μM
|
Q5AJ71-1-F |
Carbonic Anhydrase (cluster #1 Of 4), Fungal |
Fungi |
15 |
0.46 |
Binding ≤ 10μM
|
Z80362-3-O |
P388 (Lymphoma Cells) (cluster #3 Of 8), Other |
Other |
610 |
0.36 |
Functional ≤ 10μM
|
Z80928-5-O |
HCT-116 (Colon Carcinoma Cells) (cluster #5 Of 9), Other |
Other |
210 |
0.39 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
2.18 |
-0.04 |
-47.41 |
3 |
7 |
-1 |
124 |
384.846 |
4 |
↓
|
Mid
Mid (pH 6-8)
|
2.18 |
-0.12 |
-16.96 |
4 |
7 |
0 |
122 |
385.854 |
4 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
And 2 More
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
TOP2A-1-E |
DNA Topoisomerase II Alpha (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
3300 |
0.40 |
Binding ≤ 10μM
|
KIT-1-E |
Stem Cell Growth Factor Receptor (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
200 |
0.49 |
Functional ≤ 10μM
|
Z100501-1-O |
Lu1 (Lung Carcinoma Cells) (cluster #1 Of 2), Other |
Other |
80 |
0.52 |
Functional ≤ 10μM
|
Z103204-1-O |
A427 (cluster #1 Of 4), Other |
Other |
890 |
0.45 |
Functional ≤ 10μM
|
Z103205-3-O |
A431 (cluster #3 Of 4), Other |
Other |
470 |
0.47 |
Functional ≤ 10μM
|
Z50425-3-O |
Plasmodium Falciparum (cluster #3 Of 22), Other |
Other |
501 |
0.46 |
Functional ≤ 10μM
|
Z50426-9-O |
Plasmodium Falciparum (isolate K1 / Thailand) (cluster #9 Of 9), Other |
Other |
73 |
0.53 |
Functional ≤ 10μM
|
Z80008-2-O |
5637 (Epithelial Bladder Carcinoma Cells) (cluster #2 Of 3), Other |
Other |
890 |
0.45 |
Functional ≤ 10μM
|
Z80036-2-O |
BaF3 (IL-3-dependent Pro-B-cells) (cluster #2 Of 3), Other |
Other |
200 |
0.49 |
Functional ≤ 10μM
|
Z80145-1-O |
H69 (cluster #1 Of 4), Other |
Other |
1800 |
0.42 |
Functional ≤ 10μM
|
Z80156-10-O |
HL-60 (Promyeloblast Leukemia Cells) (cluster #10 Of 12), Other |
Other |
660 |
0.46 |
Functional ≤ 10μM
|
Z80164-3-O |
HT-1080 (Fibrosarcoma Cells) (cluster #3 Of 6), Other |
Other |
4300 |
0.40 |
Functional ≤ 10μM
|
Z80186-10-O |
K562 (Erythroleukemia Cells) (cluster #10 Of 11), Other |
Other |
380 |
0.47 |
Functional ≤ 10μM
|
Z80193-4-O |
L1210 (Lymphocytic Leukemia Cells) (cluster #4 Of 12), Other |
Other |
500 |
0.46 |
Functional ≤ 10μM |
Z80224-5-O |
MCF7 (Breast Carcinoma Cells) (cluster #5 Of 14), Other |
Other |
430 |
0.47 |
Functional ≤ 10μM
|
Z80322-1-O |
NCI-H358 (Lung Carcinama Cells) (cluster #1 Of 2), Other |
Other |
200 |
0.49 |
Functional ≤ 10μM
|
Z80509-1-O |
SNU-638 (Gastric Carcinoma Cells) (cluster #1 Of 1), Other |
Other |
2000 |
0.42 |
Functional ≤ 10μM
|
Z80583-1-O |
Vero (Kidney Cells) (cluster #1 Of 7), Other |
Other |
800 |
0.45 |
Functional ≤ 10μM
|
Z80682-7-O |
A549 (Lung Carcinoma Cells) (cluster #7 Of 11), Other |
Other |
470 |
0.47 |
Functional ≤ 10μM
|
Z80784-1-O |
Col2 (Colon Carcinoma Cells) (cluster #1 Of 2), Other |
Other |
2300 |
0.42 |
Functional ≤ 10μM
|
Z80928-5-O |
HCT-116 (Colon Carcinoma Cells) (cluster #5 Of 9), Other |
Other |
410 |
0.47 |
Functional ≤ 10μM
|
Z81024-8-O |
NCI-H460 (Non-small Cell Lung Carcinoma) (cluster #8 Of 8), Other |
Other |
510 |
0.46 |
Functional ≤ 10μM
|
Z81115-3-O |
KB (Squamous Cell Carcinoma) (cluster #3 Of 6), Other |
Other |
812 |
0.45 |
Functional ≤ 10μM
|
Z81115-3-O |
KB (Squamous Cell Carcinoma) (cluster #3 Of 6), Other |
Other |
1780 |
0.42 |
Functional ≤ 10μM |
Z81170-5-O |
LNCaP (Prostate Carcinoma) (cluster #5 Of 5), Other |
Other |
3250 |
0.40 |
Functional ≤ 10μM
|
Z81247-2-O |
HeLa (Cervical Adenocarcinoma Cells) (cluster #2 Of 9), Other |
Other |
310 |
0.48 |
Functional ≤ 10μM
|
Z81252-10-O |
MDA-MB-231 (Breast Adenocarcinoma Cells) (cluster #10 Of 11), Other |
Other |
2300 |
0.42 |
Functional ≤ 10μM
|
Z81277-1-O |
NCI-N417 (cluster #1 Of 2), Other |
Other |
870 |
0.45 |
Functional ≤ 10μM
|
Z80156-2-O |
HL-60 (Promyeloblast Leukemia Cells) (cluster #2 Of 4), Other |
Other |
2600 |
0.41 |
ADME/T ≤ 10μM
|
Z80164-1-O |
HT-1080 (Fibrosarcoma Cells) (cluster #1 Of 1), Other |
Other |
5010 |
0.39 |
ADME/T ≤ 10μM
|
Z80193-2-O |
L1210 (Lymphocytic Leukemia Cells) (cluster #2 Of 4), Other |
Other |
190 |
0.50 |
ADME/T ≤ 10μM
|
Z80583-3-O |
Vero (Kidney Cells) (cluster #3 Of 3), Other |
Other |
3820 |
0.40 |
ADME/T ≤ 10μM |
Z80583-3-O |
Vero (Kidney Cells) (cluster #3 Of 3), Other |
Other |
5500 |
0.39 |
ADME/T ≤ 10μM
|
Z80682-1-O |
A549 (Lung Carcinoma Cells) (cluster #1 Of 3), Other |
Other |
2070 |
0.42 |
ADME/T ≤ 10μM
|
Z80784-1-O |
Col2 (Colon Carcinoma Cells) (cluster #1 Of 1), Other |
Other |
1820 |
0.42 |
ADME/T ≤ 10μM
|
Z80951-1-O |
NIH3T3 (Fibroblasts) (cluster #1 Of 1), Other |
Other |
3 |
0.63 |
ADME/T ≤ 10μM
|
Z81057-4-O |
HUVEC (Umbilical Vein Endothelial Cells) (cluster #4 Of 5), Other |
Other |
370 |
0.47 |
ADME/T ≤ 10μM
|
Z81115-1-O |
KB (Squamous Cell Carcinoma) (cluster #1 Of 3), Other |
Other |
5300 |
0.39 |
ADME/T ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
4.28 |
8.05 |
-7.84 |
1 |
2 |
0 |
29 |
246.313 |
0 |
↓
|
Lo
Low (pH 4.5-6)
|
4.28 |
8.52 |
-35.14 |
2 |
2 |
1 |
30 |
247.321 |
0 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
And 15 More
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
CCNB1-1-E |
G2/mitotic-specific Cyclin B1 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
56 |
0.41 |
Binding ≤ 10μM
|
CCNB2-1-E |
G2/mitotic-specific Cyclin B2 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
56 |
0.41 |
Binding ≤ 10μM
|
CCNB3-1-E |
G2/mitotic-specific Cyclin B3 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
56 |
0.41 |
Binding ≤ 10μM
|
CDK1-1-E |
Cyclin-dependent Kinase 1 (cluster #1 Of 4), Eukaryotic |
Eukaryotes |
56 |
0.41 |
Binding ≤ 10μM
|
CLK3-1-E |
Dual Specificity Protein Kinase CLK3 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
41 |
0.41 |
Binding ≤ 10μM
|
CSK21-1-E |
Casein Kinase II Alpha (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
1 |
0.50 |
Binding ≤ 10μM
|
DAPK3-1-E |
Death-associated Protein Kinase 3 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
17 |
0.44 |
Binding ≤ 10μM
|
FLT3-1-E |
Tyrosine-protein Kinase Receptor FLT3 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
55 |
0.41 |
Binding ≤ 10μM
|
HIPK3-1-E |
Homeodomain-interacting Protein Kinase 3 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
45 |
0.41 |
Binding ≤ 10μM
|
PIM1-1-E |
Serine/threonine-protein Kinase PIM1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
46 |
0.41 |
Binding ≤ 10μM
|
TBK1-1-E |
Serine/threonine-protein Kinase TBK1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
35 |
0.42 |
Binding ≤ 10μM
|
Z103203-2-O |
A375 (cluster #2 Of 3), Other |
Other |
3900 |
0.30 |
Functional ≤ 10μM
|
Z80186-6-O |
K562 (Erythroleukemia Cells) (cluster #6 Of 11), Other |
Other |
5300 |
0.30 |
Functional ≤ 10μM
|
Z80224-5-O |
MCF7 (Breast Carcinoma Cells) (cluster #5 Of 14), Other |
Other |
8900 |
0.28 |
Functional ≤ 10μM
|
Z80390-1-O |
PC-3 (Prostate Carcinoma Cells) (cluster #1 Of 10), Other |
Other |
2100 |
0.32 |
Functional ≤ 10μM
|
Z80682-1-O |
A549 (Lung Carcinoma Cells) (cluster #1 Of 11), Other |
Other |
3000 |
0.31 |
Functional ≤ 10μM
|
Z80928-5-O |
HCT-116 (Colon Carcinoma Cells) (cluster #5 Of 9), Other |
Other |
2200 |
0.32 |
Functional ≤ 10μM
|
Z81072-6-O |
Jurkat (Acute Leukemic T-cells) (cluster #6 Of 10), Other |
Other |
2500 |
0.31 |
Functional ≤ 10μM
|
Z81170-1-O |
LNCaP (Prostate Carcinoma) (cluster #1 Of 5), Other |
Other |
4700 |
0.30 |
Functional ≤ 10μM
|
Z81252-3-O |
MDA-MB-231 (Breast Adenocarcinoma Cells) (cluster #3 Of 11), Other |
Other |
6400 |
0.29 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
5.14 |
10.5 |
-55.54 |
1 |
5 |
-1 |
78 |
348.769 |
3 |
↓
|
Hi
High (pH 8-9.5)
|
1.84 |
5.03 |
-92.09 |
7 |
8 |
2 |
122 |
456.497 |
5 |
↓
|
|